ADC manufacturing
ADC manufacturing
AstraZeneca Unveils $300M Game-Changer for Cell Therapy
AstraZeneca's new $300M plant in Rockville enhances CAR T therapy production, ensuring high-quality, patient-specific treatments! 🌟🏭💡🔍 CellTherapy
Revolutionary Technique Cuts Costs in Gene Therapy!
Unlocking gene therapy's potential! 🌟 Mass photometry simplifies production by identifying viral vectors efficiently—no purification needed! 🚀💡 Innovation
Roche’s $50B US Boost: Jobs and Growth Ahead!
Roche is investing $50B in U.S. manufacturing and R&D, creating jobs and addressing looming tariffs! 🇺🇸🏭📈 Biopharma Investment
Revolutionizing AAV Quality for Safer Gene Therapies
🔬 Discover how advancements in AAV quality control can enhance cell and gene therapy! 🧬 Standardized protocols lead to safer treatments! 📈✨
Revolutionizing Gene Therapy: AI and Automation Unleashed!
Discover how 🤖 automation and AI are transforming cell and gene therapy production, ensuring quality control and affordability in healthcare! 🏭✨
UK Invests Big in Advanced Therapy Manufacturing!
The U.K. is bullish on advanced therapy manufacturing! 💪💰 £520 million investment fosters innovation and retains gene therapies. 🚀🌍
€50 Million Boost for GLP-1 Production in France!
🌟 Axplora invests €50M in France! 🏗️ Boosting GLP-1 manufacturing for diabetes and obesity therapies. 💊 Next-gen production by 2026! 🚀
Ireland’s Power Duo Tackles Biopharma Bottlenecks!
🌟 Ireland's SSPC and NIBRT unite to tackle biopharma bottlenecks! 🔍 Focusing on R&D enhancements and productivity solutions. 🏭 A game-changer!
Lonza Doubles Capacity Adds 200 Jobs in Switzerland!
Lonza expands its Visp facility with two new bioconjugation suites, creating 200 jobs and doubling capacity for antibody-drug conjugates! 🌍🏗️💼📈🌱
MilliporeSigma Boosts Cancer Treatment with $76M Investment!
MilliporeSigma invests $76M to triple ADC manufacturing capacity! 🌟 Accelerating new cancer therapies for better patient outcomes. 📈💊
